FORWARD LOOK Looking for Brain Metastases Studies aim to identify when screening is beneficial. by Sue Rochman Forward Look In Women, Lung Cancer Rates Are Rising Worldwide Lung cancer deaths are set to surpass breast cancer deaths in many regions. by Cameron Walker Why I Put Down My Camera A professional photographer shares advice on living in the moment after caring for his father, who had stage IV lung cancer. by Jay Perry Survivor Profile The Power of Patients Janet Freeman-Daily helps put patients at the center of lung cancer research. by Robin Meadows A Sense of Purpose In a Facebook Live discussion about When Breath Becomes Air, Lucy Kalanithi talks about safeguarding a person’s identity in the face of terminal disease and shares tips and resources for caregiving. by Marci A. Landsmann Exploring When Breath Becomes Air Join our Facebook group to talk about themes in the poignant memoir by Paul Kalanithi. by Marci A. Landsmann Forward Look Lung Cancer Biology Differs by Race, Study Shows Research findings could help improve personalized treatments for lung cancer patients. by Stephen Ornes Non–Small Cell Lung Cancer Takes Center Stage A trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non–small cell lung cancer treatment. by Brad Jones Forward Look Treating Early-Stage Lung Cancer Efforts are underway to define role of high-dose radiation. by Stephen Ornes When Cancer Survivors Get Another Cancer Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials. by Kate Yandell next Cancer Talk New Rule Would Require Breast Density Disclosure A proposed federal rule says that patients must be informed after mammograms if they have dense breasts. by Carly Weeks PARP Inhibitors in Pancreatic Cancer Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer. by Kate Yandell Telling Their Stories Through Posters Survivors and advocates display their posters alongside the work of thousands of cancer researchers. by Kevin McLaughlin The Crowded Field of Checkpoint Inhibitors Drug developers behind the six currently approved checkpoint inhibitors discuss the pros and cons of competition in the field. by Kate Yandell More Posts